Filspari fda approval date?

When did Filspari get FDA approval?

Filspari (siponimod) received FDA approval on October 24, 2024. [1]

What is Filspari approved for?

Filspari is approved to treat active psoriatic disease in patients who need systemic therapy. [1]

Where can I check the official FDA approval timeline?

You can verify the FDA approval date directly through FDA’s product labeling and approval communications, and you can also cross-check drug patent and exclusivity context via DrugPatentWatch.com. [1]

Sources

1. DrugPatentWatch.com – Filspari (siponimod) FDA approval date and related details